Loading…
Loading…
West Pharmaceutical Services (NYSE: WST - Get Free Report) and Acutus Medical (NASDAQ: AFIB - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends. Volatility and Risk West Pharmaceutical Services has
Benjamin Edwards Inc. grew its stake in West Pharmaceutical Services, Inc. (NYSE: WST) by 47.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,322 shares of the medical instruments supplier's stock after buying an additional 1,720 shares
West Pharmaceutical Services, Inc. (NYSE: WST - Get Free Report) has earned an average rating of "Moderate Buy" from the fifteen brokerages that are currently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has assigned a strong buy recommendation to the
Caisse de depot et placement du Quebec purchased a new stake in West Pharmaceutical Services, Inc. (NYSE: WST) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,730 shares of the medical instruments supplier's stock, valued at approximately $2,775,000. Several
EXTON, Pa., Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: Wells Fargo Annual Healthcare Conference on Thursday, September 10, 2026 at 8:45 a.m. EDT in Everett, MA Morgan Stanley Annual Global Healthcare Conference on Monday, September 14, 2026 at 8:30 a.m.
Barbara Oil Co. acquired a new stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 3,700 shares of the medical instruments supplier's stock, valued at approximately $1,339,000. Other institutional investors and hedge funds
Advisors Capital Management LLC bought a new stake in West Pharmaceutical Services, Inc. (NYSE: WST) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,270 shares of the medical instruments supplier's stock, valued at approximately $1,533,000. A number
West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.